To amend the Federal Food, Drug, and Cosmetic Act and Public Health Service Act to advance the next-generation of clinical development of novel treatments and cures, and for other purposes.
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
Based on the bill's title, H.R. 10857 would amend the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to address the clinical development of new treatments and cures. The full text was not available, so the specific provisions and mechanisms cannot be confirmed. The bill was referred to the House Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for consideration of provisions within their respective jurisdictions.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.